- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 836179, 8 pages
A Metabolomics-Based Strategy for the Quality Control of Traditional Chinese Medicine: Shengmai Injection as a Case Study
1College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350108, China
2Center for Translational Biomedical Research, University of North Carolina at Greensboro, North Carolina Research Campus, Kannapolis, NC 28081, USA
Received 6 December 2012; Accepted 19 December 2012
Academic Editor: Aiping Lu
Copyright © 2013 Xiaodong Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- N. Gilbert, Chinese Herbal Medicine Breaks into EU Market, 2012.
- G. B. Mahady, H. S. Fong, and N. R. Farnsworth, Botanical Dietary Supplements: Quality, Safety, and Efficacy, Swets & Zeitlinger, Amsterdam, The Netherlands, 2001.
- X. Di, K. K. C. Chan, H. W. Leung, and C. W. Huie, “Fingerprint profiling of acid hydrolyzates of polysaccharides extracted from the fruiting bodies and spores of Lingzhi by high-performance thin-layer chromatography,” Journal of Chromatography A, vol. 1018, no. 1, pp. 85–95, 2003.
- FDA Guidance for Industry—Botanical Drug Products (Draft Guidance), US Food and Drug Administration, Rockville, Md, USA, 2000.
- Note for Guidance on Quality, of Herbal Medicinal Products, European Medicines Agency, London, UK, 2001.
- P. S. Xie, “A feasible strategy for applying chromatography fingerprint to assess quality of Chinese herbal medicine,” in Proceedings of the International Symposium on Quality of TCM with Chromatographic Fingerprint, Guangzhou, China, 2001.
- R. Capasso, A. A. Izzo, L. Pinto, T. Bifulco, C. Vitobello, and N. Mascolo, “Phytotherapy and quality of herbal medicines,” Fitoterapia, vol. 71, no. 1, pp. S58–S65, 2000.
- L. W. Yang, D. H. Wu, X. Tang et al., “Fingerprint quality control of Tianjihuang by high-performance liquid chromatography-photodiode array detection,” Journal of Chromatography A, vol. 1070, no. 1-2, pp. 35–42, 2005.
- O. Sticher, “Quality of Ginkgo preparations,” Planta Medica, vol. 59, no. 1, pp. 2–11, 1993.
- WHO, Guidelines for the Assessment of Herbal Medicines, World Health Organization, Munich, Germany, 1991.
- State Food and Drug Administration of China, Note for Studying Fingerprint of Traditional Chinese Medicine Injections (Draft), Shanghai, China, 2000.
- O. Fiehn, “Metabolomics—the link between genotypes and phenotypes,” Plant Molecular Biology, vol. 48, no. 1-2, pp. 155–171, 2002.
- S. Rochfort, “Metabolomics reviewed: a new “omics” platform technology for systems biology and implications for natural products research,” Journal of Natural Products, vol. 68, no. 12, pp. 1813–1820, 2005.
- K. Lan and W. Jia, “An Integrated metabolomics and pharmacokinetics strategy for multi-component drugs evaluation,” Current Drug Metabolism, vol. 11, no. 1, pp. 105–114, 2010.
- E. C. Y. Chan, S. L. Yap, A. J. Lau, P. C. Leow, D. F. Toh, and H. L. Koh, “Ultra-performance liquid chromatography/time-of-flight mass spectrometry based metabolomics of raw and steamed Panax notoginseng,” Rapid Communications in Mass Spectrometry, vol. 21, no. 4, pp. 519–528, 2007.
- J. L. Wolfender, G. Glauser, J. Boccard, and S. Rudaz, “MS-based plant metabolomic approaches for biomarker discovery,” Natural Product Communications, vol. 4, no. 10, pp. 1417–1430, 2009.
- G. Xie, R. Plumb, M. Su et al., “Ultra-performance LC/TOF MS analysis of medicinal Panax herbs for metabolomic research,” Journal of Separation Science, vol. 31, no. 6-7, pp. 1015–1026, 2008.
- H. Dai, C. Xiao, H. Liu, and H. Tang, “Combined NMR and LC-MS analysis reveals the metabonomic changes in salvia miltiorrhiza bunge induced by water depletion,” Journal of Proteome Research, vol. 9, no. 3, pp. 1460–1475, 2010.
- H. Dai, C. Xiao, H. Liu, F. Hao, and H. Tang, “Combined NMR and LC-DAD-MS analysis reveals comprehensive metabonomic variations for three phenotypic cultivars of salvia miltiorrhiza bunge,” Journal of Proteome Research, vol. 9, no. 3, pp. 1565–1578, 2010.
- X. Liang, X. Chen, Q. Liang et al., “Metabonomic study of Chinese Medicine Shuanglong Formula as an effective treatment for myocardial infarction in rats,” Journal of Proteome Research, vol. 10, no. 2, pp. 790–799, 2011.
- H. M. Zhang, S. L. Li, H. Zhang, et al., “Holistic quality evaluation of commercial white and red ginseng using a UPLC-QTOF-MS/MS-based metabolomics approach,” Journal of Pharmaceutical and Biomedical Analysis, vol. 62, pp. 258–273, 2012.
- Traditional Chinese Drug standards of Ministry of Health of the People's Republic of China, Shengmai Zhusheye (Injection) Quality Standard, Ministry of Health, Beijing, China, 1998.
- J. E. Jackson, A Users Guide to Principal Components, Wiley, New York, NY, USA, 1991.
- L. Eriksson, E. Johansson, N. Kettaneh-Wold, and S. Wold, Multi- and Megavariate Data Analysis, Umetrics Academy, Umea, Sweden, 2001.
- S. S. Zeng, L. Wang, T. Chen, et al., “Direct analysis in real time mass spectrometry and multivariate data analysis: a novel approach to rapid identification of analytical markers for quality control of traditional Chinese medicine preparation,” Analytica Chimica Acta, vol. 733, pp. 38–47, 2012.